Pancreatic Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Pancreatic Cancer, including details on symptoms, causes, treatment, information.

Volume 5 (2008), Issue 5 (May)

1. Apolipoprotein C-1 maintains cell survival by preventing from apoptosis in pancreatic cancer cells.
   Oncogene, 27(20): 2810-22. [Abstract] [Full-text]
2. Diagnosis of pancreaticobiliary malignancy by detection of minichromosome maintenance protein 5 in bile aspirates.
   Br J Cancer, 98(9): 1548-54. [Abstract] [Full-text]
3. Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia.
   Br J Cancer, 98(9): 1540-7. [Abstract] [Full-text]
4. MEK inhibitor enhances the inhibitory effect of imatinib on pancreatic cancer cell growth.
   Cancer Lett, 264(2): 241-9. [Abstract] [Full-text]
5. Most pancreatic cancer resections are R1 resections.
   Ann Surg Oncol, 15(6): 1651-60. [Abstract] [Full-text]
6. Expression of indoleamine 2,3-dioxygenase in metastatic pancreatic ductal adenocarcinoma recruits regulatory T cells to avoid immune detection.
   J Am Coll Surg, 206(5): 849-54; discussion 854-6. [Abstract] [Full-text]
7. Borderline resectable pancreatic cancer: the importance of this emerging stage of disease.
   J Am Coll Surg, 206(5): 833-46; discussion 846-8. [Abstract] [Full-text]
8. Cell adhesion molecule 1 is a novel pancreatic-islet cell adhesion molecule that mediates nerve-islet cell interactions.
   Gastroenterology, 134(5): 1544-54. [Abstract] [Full-text]
9. Polysialylated NCAM represses E-cadherin-mediated cell-cell adhesion in pancreatic tumor cells.
   Gastroenterology, 134(5): 1555-66. [Abstract] [Full-text]
10. A patient with worsening mobility: a diagnostic challenge.
    Eur J Intern Med, 19(4): 292-4. [Abstract] [Full-text]
11. Adverse prognosis of epigenetic inactivation in RUNX3 gene at 1p36 in human pancreatic cancer.
    Br J Cancer, 98(10): 1690-5. [Abstract] [Full-text]
12. Undifferentiated carcinoma with osteoclast-like giant cells arising in a mucinous cystic neoplasm of the pancreas.
    Pathol Int, 58(6): 383-9. [Abstract] [Full-text]
13. Anti-apoptotic and growth-stimulatory functions of CK1 delta and epsilon in ductal adenocarcinoma of the pancreas are inhibited by IC261 in vitro and in vivo.
    Gut, 57(6): 799-806. [Abstract] [Full-text]
14. Vascular normalization in Rgs5-deficient tumours promotes immune destruction.
    Nature, 453(7193): 410-4. [Abstract] [Full-text]
15. Enhanced distribution of NK012, a polymeric micelle-encapsulated SN-38, and sustained release of SN-38 within tumors can beat a hypovascular tumor.
    Cancer Sci, 99(6): 1258-64. [Abstract] [Full-text]
16. Sonic hedgehog derived from human pancreatic cancer cells augments angiogenic function of endothelial progenitor cells.
    Cancer Sci, 99(6): 1131-8. [Abstract] [Full-text]
17. Intraductal papillary mucinous neoplasms of the pancreas: correlation of helical CT and dynamic MR imaging features with pathologic findings.
    Abdom Imaging, 33(4): 474-81. [Abstract] [Full-text]
18. Imaging diagnosis of hepatic metastases of pancreatic carcinomas: significance of transient wedge-shaped contrast enhancement mimicking arterioportal shunt.
    Abdom Imaging, 33(4): 437-43. [Abstract] [Full-text]
19. Granulocytic sarcoma of Core-binding Factor (CBF) acute myeloid leukemia mimicking pancreatic cancer.
    Leuk Res, 32(9): 1472-5. [Abstract] [Full-text]
20. Prospective phase II trial of neoadjuvant chemotherapy with gemcitabine and cisplatin for resectable adenocarcinoma of the pancreatic head.
    J Clin Oncol, 26(15): 2526-31. [Abstract] [Full-text]
21. Resection margins and R1 rates in pancreatic cancer--are we there yet?
    Histopathology, 52(7): 787-96. [Abstract] [Full-text]
22. Preoperative prediction of complete resection in pancreatic cancer.
    J Surg Res, 147(2): 216-20. [Abstract] [Full-text]
23. A pilot study of perillyl alcohol in pancreatic cancer.
    J Surg Res, 147(2): 194-9. [Abstract] [Full-text]
24. Cystic pancreatic endocrine neoplasms: a distinct tumor type?
    J Am Coll Surg, 206(3): 1154-8. [Abstract] [Full-text]
25. Uncommon tumors and pseudotumoral lesions of the pancreas.
    Curr Probl Diagn Radiol, 37(4): 145-64. [Abstract] [Full-text]
26. Phase I trial of the human immunodeficiency virus protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer.
    J Clin Oncol, 26(16): 2699-706. [Abstract] [Full-text]
27. The CM cell line derived from liver metastasis of malignant human insulinoma is not a valid beta cell model for in vitro studies.
    J Cell Physiol, 216(2): 569-70. [Abstract] [Full-text]
28. Role of the WWOX gene, encompassing fragile region FRA16D, in suppression of pancreatic carcinoma cells.
    Cancer Sci, 99(7): 1370-6. [Abstract] [Full-text]
29. Induction of hepatocyte growth factor activator gene expression under hypoxia activates the hepatocyte growth factor/c-Met system via hypoxia inducible factor-1 in pancreatic cancer.
    Cancer Sci, 99(7): 1341-7. [Abstract] [Full-text]
30. Gli1 contributes to the invasiveness of pancreatic cancer through matrix metalloproteinase-9 activation.
    Cancer Sci, 99(7): 1377-84. [Abstract] [Full-text]

© 2004-2010 Pancreatic Cancer Research Today. All Rights Reserved.